188 LEPTIN INDUCES DETRIMENTAL CHANGES IN HUMAN OA CARTILAGE. EFFECTS ON NITRIC OXIDE, PGE2, IL-6 AND IL-8 PRODUCTION  by Vuolteenaho, K. et al.
Osteoarthritis and Cartilage Vol. 15, Supplement C C111
placement. Chondrocytes were isolated by digestion with colla-
genase and used in primary culture. Cells were stimulated with
IL-1β for different times in the presence or absence of CORM-2
(50, 100 or 150 µM). Gene expression was analyzed by real-
time PCR. Protein expression was investigated by Western blot
method and immunocytochemistry. Aggrecanase activity, MMP
protein levels and phosphorylated/total levels of ERK and IκBα
were determined by ELISA, and NF-κB activity by the luciferase
method.
Results: CORM-2 treatment increased cell viability and collagen
II and aggrecan protein expression in primary OA chondrocytes.
Increased gene expression of collagen II, aggrecan, link pro-
tein, Sox-9 and BMP2 was observed. Interestingly, aggrecanase
activity was reduced by CORM-2 in a concentration-dependent
manner, as well as gene expression and protein levels of MMP-
1, MMP-3 and MMP-10. Our results also indicate that down-
regulation of cartilage degradative enzymes by CORM-2 may be
mediated by the inhibition of ERK and IκBα phosphorylation, and
of NF-κB activation.
Conclusions: CO released by CORM-2 enhances matrix com-
ponents and decreases the production of MMP and aggrecanase
activities induced by IL-1β in OA chondrocytes, indicating the po-
tential interest of this class of compounds in cartilage protection.
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Purpose: Obesity is an important risk factor for OA of weight-
bearing joints, but also for hand joints pointing to an obesity-
related metabolic factor that inﬂuences on the susceptility or
pathogenesis of OA. Leptin is a proinﬂammatory adipokine reg-
ulating energy balance and it has lately been related also to
arthritis and cartilage metabolism. In the present study, we in-
vestigated the effects of leptin on human OA cartilage.
Methods: Cartilage tissue obtained from the leftover pieces of
total knee replacement surgery from patients with OA were used
in the experiments.
Results: Leptin alone and in combination with IL-1 induced
iNOS expression and NO production, COX-2 expression and
PGE2 production, and IL-6 and IL-8 secretion in human OA
cartilage in a concentration dependent manner. The effects of
leptin were mediated through transcription factor NF-kB and
MAP kinases JNK and p38 (the latter only in the case of COX-2
and PGE). In addition, JAK-STAT pathway seems to mediate
the leptin effect on iNOS and NO. There were signiﬁcant inter-
individual differences in the responsiveness to exogenous leptin,
and its relation to BMI, severity of OA, and SOCS-3 expression
was assessed.
Conclusions: The ﬁndings support the idea of leptin as a detri-
mental factor in OA cartilage and as a link between obesity and
increased risk for osteoarthritis.
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Purpose: Chondrocyte hypertrophy is a morphologic feature of
both the normal calciﬁed cartilage layer of the articular plate and
of uncalciﬁed cartilage in pathologic states such as osteoarthri-
tis. The relationships of chondrocyte hypertrophy to chondrocyte
matrix domains and to cartilage maturation, although commonly
observed, are not well understood. As we have recently demon-
strated (Osteoarthritis and Cart, 14(Suppl B 2006): pS147, De-
cember 2006), ank-/- mice show an increased population of
hypertrophic chondrocytes in the uncalciﬁed cartilage layer. To
determine whether chondrocyte hypertrophy is a generalized
feature of ank-/- mice and to determine implications on calci-
ﬁed cartilage matrix and subchondral bone, we extended our
studies to examine chondrocyte size in calciﬁed and epiphy-
seal cartilages and their relationships to calciﬁed cartilage and
subchondral bone thickness.
Methods: Knee joints in 18 mice, homozygous (ank-/-), and con-
trols (ank+/+), 3 mice each at each of the following 3 time points:
6 weeks, 12 weeks and 18 weeks were studied. Five µm sec-
tions from ﬁxed, decalciﬁed, parafﬁn-embedded knee joints were
stained with hematoxylin and eosin. Chondrocyte size distribution
and cartilage matrix domains were determined for uncalciﬁed,
calciﬁed and epiphyseal cartilages, as well as subchondral bone
thickness. The measurements were performed on a Visiopharm
Integrator Image Analysis System, Leica DM 4500 3 microscope
and an Olympus D70 camera. With selection of the central 50%
of the tibial plateau articular plate and underlying epiphysis, as
the region of interest, the chondron areas of chondrons con-
taining nucleated chondrocytes were measured for uncalciﬁed,
calciﬁed and epiphyseal cartilage. As well, uncalciﬁed cartilage,
calciﬁed cartilage and subchondral bone thicknesses and areas
were measured over the study region.
Results: We observed that compared to wild type controls, ank
chondrocytes in uncalciﬁed cartilage and epiphyseal cartilage at
all ages were enlarged. In contrast, within calciﬁed cartilage, the
ank chondrocytes were smaller than controls at 12 and 18 weeks.
Calciﬁed cartilage in ank mice was signiﬁcantly thicker at all ages.
Conversely, subchondral bone thickness in ank mice although
thicker than controls at 6 weeks, was signiﬁcantly thinner at 18
weeks of age.
Results: typically at 18 weeks
Wild Type ank Mice
Calciﬁed cartilage thickness (µm) 59±12 86±11
Subchondral bone thickness (µm) 423±18 331±12
Conclusions: ank-/ank- mice have a generalized defect in chon-
drocytes which leads to chondrocyte hypertrophy of uncalciﬁed
and epiphyseal chondrocytes. These changes are associated
with increased calciﬁed cartilage thickness, which in turn ap-
pears related to decreased bone thickness within the articular
plate. The intriguing predicted implication is that uncalciﬁed chon-
drocyte hypertrophy, which in osteoarthritis is focal, may result
in focally thinner underlying subchondral bone. This subchondral
bone, in turn, would more readily permit microfractures leading to
articular plate remodelling, a characteristic feature of osteoarthri-
tis.
